Determining key residues of engineered scFv antibody variants with improved MMP-9 binding using deep sequencing and machine learning is a research paper published in Computational and Structural Biotechnology Journal (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R03AG070511
National Institutes of Health
Grant: R21HD109743
National Institutes of Health
Grant: 1R03AG070511-01A1
Directed evolution of tissue inhibitor of metalloproteinase 3 (TIMP-3) to develop novel Alzheimer’s disease (AD) therapeutics
National Institutes of Health
Grant: 1R21HD109743-01
Selective targeting of matrix metalloproteinases for developing preterm labor therapeutics
Keywords